{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T14:03:27Z","timestamp":1784383407205,"version":"3.55.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Direct"],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>In end-stage liver disease, alterations in iron metabolism can lead to iron overload and development of iron overload cardiomyopathy. In liver transplant candidates, evaluation for cardiac iron overload and dysfunction can help to identify candidates at increased risk for peritransplant morbidity and mortality, though recommendations for pretransplant evaluation of cardiac iron overload are not standardized. Cardiac Magnetic Resonance Imaging T2* (CMRI-T2*) is a validated method to quantify cardiac iron deposition, with normal T2* value of 20 ms or greater. In this study, we sought to identify the incidence and predictors of iron overload by CMRI-T2* and to evaluate the impact of cardiac and iron overload on morbidity and mortality after liver transplantation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this retrospective single-center cohort study, all liver transplant candidates who underwent a pretransplant CMRI-T2* between January 1, 2008, and June 30, 2016, were included to analyze the association between clinical characteristics and low T2* using logistic regression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>One hundred seventy-nine liver transplant candidates who received CMRI-T2* were included. Median age was 57 years, 73.2% were male, and 47.6% were white. 49.7% had hepatitis C and 2.8% had hemochromatosis. Median Model for End-Stage Liver Disease score was 25. 65.2% were Child-Pugh C. In multivariable logistic regression, T2* less than 20 ms (n = 35) was associated with Model for End-Stage Liver Disease score of 25 or greater (odds ratio [OR], 3.65; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.007), Child-Pugh C (OR, 3.42; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.03), and echocardiographic systolic ejection fraction less than 65% (OR, 2.24; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.01). Posttransplant heart failure occurred exclusively in recipients with T2* less than 15 ms. Survival was worse in T2* 10 to 14.9 versus T2* of 20 ms or greater (hazard ratio, 3.85; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.003), but not for 15 to 19.9 versus T2* of 20 ms or greater.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Severity of liver disease and systolic dysfunction is associated with T2* less than 20 ms, though there was no difference in posttransplant outcomes between T2* 15 to 19.9 and T2* 20 ms or greater, suggesting that individuals with T2* of 15 ms or greater may be suitable transplant candidates. CMRI-T2* is an additional diagnostic tool in evaluating transplant candidates at high risk for posttransplant cardiac complications.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/txd.0000000000000803","type":"journal-article","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T14:24:48Z","timestamp":1528467888000},"page":"e363","source":"Crossref","is-referenced-by-count":10,"title":["Cardiac MRI T2* in Liver Transplant Candidates: Application and Performance of a Novel Imaging Technique to Identify Patients at Risk for Poor Posttransplant Cardiac Outcomes"],"prefix":"10.1097","volume":"4","author":[{"given":"Sara M.","family":"Lewin","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University of California at San Francisco, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Kallianos","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of California at San Francisco, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Ilan","family":"Nevah","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition, University of Texas, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Santa Clara Valley Medical Center, San Jose, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren K.","family":"Fix","sequence":"additional","affiliation":[{"name":"Organ Transplant Department, Swedish Medical Center, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel C.","family":"Brooks","sequence":"additional","affiliation":[{"name":"GE Healthcare, Amersham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"De Marco","sequence":"additional","affiliation":[{"name":"GE Healthcare, Amersham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atif N.","family":"Qasim","sequence":"additional","affiliation":[{"name":"GE Healthcare, Amersham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen G.","family":"Ordovas","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of California at San Francisco, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Mehta","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University of California at San Francisco, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2018,7]]},"reference":[{"key":"bib1-20231002","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jacc.2010.03.083","article-title":"Iron overload cardiomyopathy","volume":"56","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"bib2-20231002","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/CRD.0b013e3182a67805","article-title":"Cardiac involvement in hemochromatosis","volume":"22","year":"2014","journal-title":"Cardiol Rev"},{"key":"bib3-20231002","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.111.050773","article-title":"Iron overload cardiomyopathy in clinical practice","volume":"124","year":"2011","journal-title":"Circulation"},{"key":"bib4-20231002","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/his.12417","article-title":"Iron overload secondary to cirrhosis: a mimic of hereditary haemochromatosis?","volume":"65","year":"2014","journal-title":"Histopathology"},{"key":"bib5-20231002","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1478-3231.2005.01004.x","article-title":"Hepatic iron overload in alcoholic end-stage liver disease is associated with iron deposition in other organs in the absence of HFE-1 hemochromatosis","volume":"25","year":"2005","journal-title":"Liver Int"},{"key":"bib6-20231002","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/TP.0b013e31819f2280","article-title":"Marked iron in liver explants in the absence of major hereditary hemochromatosis gene defects: a risk factor for cardiac failure","volume":"87","year":"2009","journal-title":"Transplantation"},{"key":"bib7-20231002","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1399-0012.2009.01136.x","article-title":"Hepatic and cardiac iron overload among patients with end-stage liver disease referred for liver transplantation","volume":"24","year":"2010","journal-title":"Clin Transplant"},{"key":"bib8-20231002","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/hep.1840200221","article-title":"Outcome of liver transplantation in patients with hemochromatosis","volume":"20","year":"1994","journal-title":"Hepatology"},{"key":"bib9-20231002","first-page":"946961","article-title":"Cardiac failure after liver transplantation requiring a biventricular assist device","volume":"2014","year":"2014","journal-title":"Case Rep Transplant"},{"key":"bib10-20231002","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.gastro.2005.05.004","article-title":"Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry","volume":"129","year":"2005","journal-title":"Gastroenterology"},{"key":"bib11-20231002","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1053\/j.gastro.2007.05.054","article-title":"Survival of liver transplant recipients with hemochromatosis in the United States","volume":"133","year":"2007","journal-title":"Gastroenterology"},{"key":"bib12-20231002","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.cardfail.2010.05.009","article-title":"Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment","volume":"16","year":"2010","journal-title":"J Card Fail"},{"key":"bib13-20231002","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0894-7317(00)90031-2","article-title":"Echocardiographic features of genetic diseases: part 2. Storage disease","volume":"13","year":"2000","journal-title":"J Am Soc Echocardiogr"},{"key":"bib14-20231002","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.110.007641","article-title":"On T2* magnetic resonance and cardiac iron","volume":"123","year":"2011","journal-title":"Circulation"},{"key":"bib15-20231002","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","article-title":"Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload","volume":"22","year":"2001","journal-title":"Eur Heart J"},{"key":"bib16-20231002","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1161\/CIRCULATIONAHA.109.874487","article-title":"Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major","volume":"120","year":"2009","journal-title":"Circulation"},{"key":"bib17-20231002","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jcmg.2008.05.001","article-title":"T2* magnetic resonance: iron and gold","volume":"1","year":"2008","journal-title":"JACC Cardiovasc Imaging"},{"key":"bib18-20231002","first-page":"e14","article-title":"Reversal of severe biventricular dysfunction from cardiac hemochromatosis with iron removal","volume":"6","year":"2013","journal-title":"Circ Heart Fail"},{"key":"bib19-20231002","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/TP.0b013e3182a078e9","article-title":"Exploratory use of cardiovascular magnetic resonance imaging in liver transplantation: a one-stop shop for preoperative cardiohepatic evaluation","volume":"96","year":"2013","journal-title":"Transplantation"},{"key":"bib20-20231002","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/jmri.20929","article-title":"Black-blood T2* technique for myocardial iron measurement in thalassemia","volume":"25","year":"2007","journal-title":"J Magn Reson Imaging"},{"key":"bib21-20231002","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","article-title":"Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)","volume":"19","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"bib22-20231002","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/lt.23654","article-title":"Clinical predictors of post-liver transplant new-onset heart failure","volume":"19","year":"2013","journal-title":"Liver Transpl"},{"key":"bib23-20231002","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0016-5085(97)70184-7","article-title":"Altered cardiovascular responsiveness to active tilting in nonalcoholic cirrhosis","volume":"113","year":"1997","journal-title":"Gastroenterology"},{"key":"bib24-20231002","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1726-4901(08)70134-5","article-title":"Cardiovascular dysfunction in patients with end-stage liver disease","volume":"71","year":"2008","journal-title":"J Chin Med Assoc"},{"key":"bib25-20231002","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/bjh.12655","article-title":"Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients","volume":"164","year":"2014","journal-title":"Br J Haematol"},{"key":"bib26-20231002","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1179\/1607845413Y.0000000140","article-title":"Role of non-invasive assessment in prediction of preclinical cardiac affection in multi-transfused thalassaemia major patients","volume":"19","year":"2014","journal-title":"Hematology"},{"key":"bib27-20231002","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1007\/s00380-016-0814-1","article-title":"Is cardiac and hepatic iron status assessed by MRI T2* associated with left ventricular function in patients with idiopathic cardiomyopathy?","volume":"31","year":"2016","journal-title":"Heart Vessels"},{"key":"bib28-20231002","first-page":"231","article-title":"The association between serum ferritin level, tissue Doppler echocardiography, cardiac T2* MRI, and heart rate recovery in patients with beta thalassemia major","volume":"32","year":"2016","journal-title":"Acta Cardiol Sin"},{"key":"bib29-20231002","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1182\/blood-2003-06-1919","article-title":"Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease","volume":"103","year":"2004","journal-title":"Blood"},{"key":"bib30-20231002","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1478-3231.2005.01022.x","article-title":"Hemosiderosis is associated with accelerated decompensation and decreased survival in patients with cirrhosis","volume":"25","year":"2005","journal-title":"Liver Int"},{"key":"bib31-20231002","doi-asserted-by":"crossref","first-page":"e0172147","DOI":"10.1371\/journal.pone.0172147","article-title":"Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome","volume":"12","year":"2017","journal-title":"PLoS One"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01845228-201807000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T07:08:46Z","timestamp":1696230526000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01845228-201807000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000000803","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}